Thanks fir sharing.

Agreed

The Connected World LIVE! formerly known as the Connectbase Customer Summit is the premier industry event that brings together members of the Connectbase ecosystem.

https://connectbase-2405959.hs-sites.com/customer-summit-2024-homepage?__hstc=24101861.30e793457229f85e11b62d38428cd201.1720897337468.1720897337468.1720897337468.1&__hssc=24101861.1.1720897337468&__hsfp=1451360413

Yes R2R, WOW, still hold some just for proof it did happen. Legendary for a lucky few.

Agreed but will say 99% are scams. Time will tell here if DD plays out as another gem !$!
Lets see the beginning of the beginning

GLTUA

Nice find!

Liking the DD here, thank you all. Took a starter.

FRHC was BMBM shell. Started at .01, to otcqb, then 1/23 rs then to naz. Today over $75.00 and still going. Took 5 years.

Lightening in a bottle, can happen.

B/B !!! Congratulations Timur!

Looks like never

In 2021, Nuance Pharma entered into an agreement with Verona Pharma for the exclusive rights to develop and commercialize ensifentrine in Greater China. On April 6th 2023, Nuance Pharma announced first patient in (FPI) for the ENHANCE-China Phase III clinical trial.

https://finance.yahoo.com/news/nuance-pharmas-partner-verona-pharma-090700900.html

Should be good return here!

Agreed. ADL's nearly last to go in advanced stages in my experience 30+ yrs in healthcare.

Thank you

Thanks for sharing summation found.

Fiscal year report astounding!

Damn Timur is still killing it! Wow!

thanks for sharing

Agreed

The COGNISION® System is also used by clinicians to evaluate patients suffering from Alzheimer's disease and concussion.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced that it will present at the Noble Capital Markets Virtual Healthcare Equity Conference. Christopher U Missling, PhD, President & Chief Executive Officer is scheduled to present at 1:30pm ET, TRACK 2 on Thursday, April 18th, 2024.

A live audio webcast will be accessible through the Investors section of the Company’s website at www.anavex.com. An archived edition of the session will be available later that day.

https://www.anavex.com/post/anavex-life-sciences-to-present-at-the-noble-capital-markets-virtual-healthcare-equity-conference

4/18/24

Certainly a departure from the norm... hopefully know soon if positive.

Good to hear from you. Best to all and the twins.

Thank you for sharing! Best wishes for you sab!

Congratulations! Keep up that PT!!!

Agreed. Bodes well for avxl and delays.

https://www.neurologylive.com/view/fda-issues-revised-draft-guidance-drug-development-early-ad


The FDA's revised guidance aims to streamline drug development for early-stage AD by focusing on diagnostic criteria and outcome measures.
Surrogate endpoints, like biomarkers, are suggested for use in clinical trials to predict clinical benefit in patients with early AD.
Drug developers are encouraged to engage with the FDA early in the development process regarding the use of surrogate endpoints for AD treatment trials.

True

Yes, we could get lucky after all. (With more time, lol)

http://www.recentcare.com.tw/milestones_page?menuid=9


"Unfunded"
https://tracxn.com/d/companies/hidramed-solutions/__vZ4wZt8O7CnzIFAUGK591Z-5ZKgzrnWHz0lfWIPfmKA/competitors

Alrighty then. See what plays out now....

BHPA post-merger is now the business of Aquiva described supra.

The mission of Aquiva is to leverage its proprietary AQUIPHER(TM) technologies to facilitate the development and manufacturing of transdermal patches with larger varieties of active ingredients and to work with partners to bring these patches to the market.

Huge $$ in weight loss and seems to help with depression. Hmmm ol gut biome connection we have heard about in our pipeline

Thanks, interesting.

this theory will be tested soon and shall all see
"From here, we should begin to see short covering and more institutions starting to take/increase long positions. It's all by design."

More trial stats input:

https://ecommons.cornell.edu/items/d17a7470-70e5-4e55-bda3-8ff815aafc85

STATISTICAL ISSUES IN THE DESIGN AND ANALYSIS OF CLINICAL TRIALS
A Dissertation
Presented to the Faculty of the Graduate School
of Cornell University
In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy
by Yanning Liu Aug, 2016

Agreed. Hope now is a buyer of shell.

Thank you Xena

Interesting. Thanks

An vs down 10%. Others as well. Idk.

https://www.bbc.com/news/health-68126907.amp

Medicine stopped in 1980s linked to rare Alzheimer's cases

Correct